Literature DB >> 25634357

Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Roselyne Y Wagner1, Flavie Luciani1, Muriel Cario-André2, Alain Rubod1, Valérie Petit1, Laila Benzekri3, Khaled Ezzedine2, Sébastien Lepreux4, Eirikur Steingrimsson5, A Taieb2, Yvon Gauthier6, Lionel Larue7, Véronique Delmas1.   

Abstract

Vitiligo is the most common depigmenting disorder resulting from the loss of melanocytes from the basal epidermal layer. The pathogenesis of the disease is likely multifactorial and involves autoimmune causes, as well as oxidative and mechanical stress. It is important to identify early events in vitiligo to clarify pathogenesis, improve diagnosis, and inform therapy. Here, we show that E-cadherin (Ecad), which mediates the adhesion between melanocytes and keratinocytes in the epidermis, is absent from or discontinuously distributed across melanocyte membranes of vitiligo patients long before clinical lesions appear. This abnormality is associated with the detachment of the melanocytes from the basal to the suprabasal layers in the epidermis. Using human epidermal reconstructed skin and mouse models with normal or defective Ecad expression in melanocytes, we demonstrated that Ecad is required for melanocyte adhesiveness to the basal layer under oxidative and mechanical stress, establishing a link between silent/preclinical, cell-autonomous defects in vitiligo melanocytes and known environmental stressors accelerating disease expression. Our results implicate a primary predisposing skin defect affecting melanocyte adhesiveness that, under stress conditions, leads to disappearance of melanocytes and clinical vitiligo. Melanocyte adhesiveness is thus a potential target for therapy aiming at disease stabilization.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25634357     DOI: 10.1038/jid.2015.25

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  47 in total

Review 1.  Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation.

Authors:  Carien M Niessen; Deborah Leckband; Alpha S Yap
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 3.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

4.  Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.

Authors:  Anne Sophie Ricard; Catherine Pain; Alexia Daubos; Khaled Ezzedine; Isabelle Lamrissi-Garcia; Alice Bibeyran; Veronique Guyonnet-Dupérat; Alain Taieb; Muriel Cario-André
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

5.  Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-02-17       Impact factor: 8.551

Review 6.  Vitiligo, reactive oxygen species and T-cells.

Authors:  Steven J Glassman
Journal:  Clin Sci (Lond)       Date:  2011-02       Impact factor: 6.124

7.  Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo.

Authors:  K U Schallreuter; N C J Gibbons; C Zothner; M M Abou Elloof; J M Wood
Journal:  Biochem Biophys Res Commun       Date:  2007-06-11       Impact factor: 3.575

8.  Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin.

Authors:  A Reichert-Faria; J E Jung; V Moreschi Neto; C C Silva de Castro; M T Mira; L Noronha
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-27       Impact factor: 6.166

9.  DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.

Authors:  Yi-Chun Yeh; Chia-Ching Wu; Yang-Kao Wang; Ming-Jer Tang
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

10.  Role of keratinocytes in the development of vitiligo.

Authors:  Ai-Young Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

View more
  20 in total

1.  A New View of Vitiligo: Looking at Normal-Appearing Skin.

Authors:  Mauro Picardo; Emanuela Bastonini
Journal:  J Invest Dermatol       Date:  2015-07       Impact factor: 8.551

Review 2.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.

Authors:  Nesrine Boukhedouni; Christina Martins; Anne-Sophie Darrigade; Claire Drullion; Jérôme Rambert; Christine Barrault; Julien Garnier; Clément Jacquemin; Denis Thiolat; Fabienne Lucchese; Franck Morel; Khaled Ezzedine; Alain Taieb; François-Xavier Bernard; Julien Seneschal; Katia Boniface
Journal:  JCI Insight       Date:  2020-06-04

4.  [Vitiligo: Clinical presentation and pathogenesis].

Authors:  M Schild; M Meurer
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

Review 5.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

6.  Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.

Authors:  Ola Ahmed Bakry; Magda Mostafa Hagag; Mona Abd El Halim Kandil; Wafaa Ahmed Shehata
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 7.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

8.  Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients.

Authors:  Claire Regazzetti; Florence Joly; Carine Marty; Michel Rivier; Bruno Mehul; Pascale Reiniche; Carine Mounier; Yves Rival; David Piwnica; Marine Cavalié; Bérengère Chignon-Sicard; Robert Ballotti; Johannes Voegel; Thierry Passeron
Journal:  J Invest Dermatol       Date:  2015-08-31       Impact factor: 8.551

Review 9.  Melanoma Risk and Melanocyte Biology.

Authors:  Julie U Bertrand; Eirikur Steingrimsson; Fanélie Jouenne; Brigitte Bressac-de Paillerets; Lionel Larue
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

Review 10.  Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.

Authors:  Emanuela Bastonini; Daniela Kovacs; Mauro Picardo
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.